Robotics investment has gotten feverish as well. At some point someone will have to ask the question: who is actually deploying robots and who is making positive gross margins doing so.
The answer is: a very very short list
From the beginning, E2B has consistently ranked near the top of the pack on performance, while also providing the most complete form of workload isolation (full microVMs), most complete lifecycle capabilities (pause/resume, snapshot, etc), and a diverse set of deployment options (BYOC).
We've never needed to benchmaxx because the years of R&D we've put into fast and secure machines tend to take care of that on their own.
Nonetheless, we participated in ComputeSDK’s 100k Burst Concurrency Benchmark and crushed it as the fastest microVM provider with a 100% success rate across 109k sandboxes.
We just keep doing what we do as the first, fastest, and most reliable Agent VM provider there is. Extremely proud of the team for being able to achieve this.
Benchmark is linked in the comments.
What happens when my vendor doesn't have access to enough compute to power my workload?
Real question that leads a lot of enterprises to BYOC.
Sometimes it's not about where you want to run a thing, but where there's literally enough compute available.
ICYMI: The New York Knicks are NBA Champions, as called by @LT__Murray and @McNuttMonica !
Thank you to all of the incredible fans for listening to @ESPNNewYork this season. Your home of the NBA Champions.
New HQ. Open doors. Live robots.
Come see what's actually running at food and CPG plants across North America - in person, on our floor.
June 11 | 4-6 PM | Bolingbrook, IL
No pitch. Just demos and drinks.
RSVP: https://t.co/nAvZQCkKap
That’s a 1 with nine zeroes followed!
The rate keeps accelerating. Any tool used by agents directly must be ready for enormous growth in the upcoming months. We started E2B with an idea that agent is our user. Now it’s finally coming true.
SPEAKER ANNOUNCEMENT
We're honored to feature:
Filip Aronshtein (@FilArons)
Co-Founder and CEO of @DiracInc
Previously announced:
>Antonio Gracias - Founder, CEO, and CIO of Valor Equity Partners
>Blake Scholl - Founder and CEO of Boom Supersonic
>Daleep Singh - Vice Chair and Chief Global Economist at PGIM
>Doug Petno - Co-CEO and CIB at JP Morgan Chase
>John Henry Harris - CEO of Harbinger
>Jim Belosic - Founder of SendCutSend
>Kelly Loeffler - SBA Administrator
>Alexis Ohanian - Founder of 776
>Ed Mehr - CEO and Co-Founder of Machina Labs
>Bryon Hargis - CEO and Co-Founder at Castelion
>Emil Michael - Under Secretary of War for Research and Engineering at DoW
>Del Costy - President and Managing Director at Siemens Digital
>Brendan Carr - FCC Chairman
>Mike Pyle - Deputy Head, BlackRock Portfolio Management Group
>Justin Lopas - Co-Founder and COO, Base Power Co.
>Augustus Doricko - CEO, Rainmaker
>Mike Solana - Chief Marketing Officer, Founders Fund
>Alan Schwartz - Executive Chairman, Guggenheim Partners, LLC
>Ambassador Waltz - U.S. Representative to the United Nations
>Dan Wright - Co-Founder and CEO of Armada >Andrew Lonsberry - CEO of Path Robotics
>Tara Murphy Dougherty - CEO of Govini
>Chris Power - CEO of Hadrian
>Mark Widmar - CEO of First Solar
>Lukas Czinger - Co-Founder and CEO of Divergent
>Jacob Helberg - Under Secretary of State for Economic Affairs
A few weeks ago, I shared data showing that Weaviate is leading the industry in agentic adoption [1], where LLMs are equipped with long-term memory to handle complex tasks
1/ US biotech is in crisis, right before AI should be saving millions.
China is stealing away our industry and has surpassed the US in blockbuster pharma deals.
The next FDA Commissioner must be a fighter, and have a plan to overhaul the agency, beat China, and unleash cures.